Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Interim Management Statement

14 Jan 2009 07:00

RNS Number : 5894L
Diploma PLC
14 January 2009
 



<>

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

FOR IMMEDIATE RELEASE

14 January 2009

DIPLOMA PLC

INTERIM MANAGEMENT STATEMENT

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing its first Interim Management Statement of the new financial yearahead of the Company's AGM to be held today at Brewers Hall, Aldermanbury SquareLondon, EC2V 7HR at 12.00 midday. This Statement relates to the period from 1 October 2008 to 31 December 2008 and includes the first quarter's trading.

The Group continues to benefit from its focus on specialised sectors and supplying essential products and services which are mostly funded by customers' operating, rather than capital, budgets.  With more than 60% of revenues generated outside the UK, the Group has also gained on translation from the significant deterioration in the value of UK sterling relative to all other major currencies. With this background, the Board is able to report an increase in Group revenues of 2% over the comparable period last year although, on a constant currency basis, Group revenues reduced by 7% over the comparable period.

In Life Sciences, the Canadian Healthcare businesses, which account for over 50% of sector revenue, continued to show steady development.  Revenue from the European businesses were somewhat reduced against a strong comparable quarter last year.

Trading in the US Seals businesses weakened in the quarter, reflecting the difficult market conditions in the broader US industrial economy. Cost reduction programmes implemented in the US operations have partly mitigated the effects of reduced operational leverage. By contrast, the performance of the European Seals businesses was strong.

In Controls, the European businesses overall delivered a steady performance, with a continued focus on relatively more buoyant, technically driven sectors. 

The deterioration in the value of UK sterling relative to all other major currencies has had a significant positive impact on the Group's results on translation. Against the comparable period last year, the US dollarthe Euro and the Canadian dollar have appreciated by 25%, 16% and 6% respectively against UK sterling. Conversely at a transaction level, the weakness of UK sterling and the deterioration of the Canadian dollar relative to the US dollar, has put pressure on gross margins in the UK and Canadian businesses, by increasing the cost of goods sold.

The Group continued to maintain a strong financial position with cash balances of £16.6m at 31 December 2008 and undrawn committed term facilities of £25.0m.

On 23 December 2008, the Group announced that it had signed contracts to acquire RT/Dygerta leading supplier of seals, o-rings and custom moulded and machine parts, based in the US, for a maximum consideration of £13.2m (US$19.75m). This acquisition formally closed on 12 January 2009 and the initial consideration paid of £9.6m (US$14.4m) has been funded in part from the Group's existing cash resources and in part by drawing down £4.7m (US$7.0m) from the Group's committed bank facility. This acquisition is expected to be immediately earnings enhancing for the Group.

In addition, as reported in the 2008 Annual Report, on 5 November 2008, the Group acquired Meditech, a small medical diagnostic company in Canada for a maximum consideration of £1.5m (C$2.9m). On completion, the initial consideration of £1.3m (C$2.4m) was funded out of the Group's existing cash resources.

Finally, pursuant to the sale and purchase agreement signed on 28 August 2007, the Group will shortly be making a payment to the vendors of AMT of £1.1m (C$2.0m) as deferred consideration. This payment was based on the performance of that business during the year ended 30 September 2008.

There have been no other significant changes in the position of the Group in the period since the publication of the Annual Report for the year ended 30 September 2008.

The next update on trading is expected to be issued as part of the Half Year results for the six months ending 31 March 2009, which are expected to be released on 11 May 2009.

Notes:

This Interim Management Statement, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes.

A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

NOTE TO EDITORS:

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

The Group employs ca. 1,000 employees and its principal operating businesses are located in the UKGermany, US and Canada.

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 21% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £150m.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAXFDFSFNEFE
Date   Source Headline
17th Jan 20184:30 pmRNSResult of AGM
17th Jan 20187:00 amRNSTrading Statement
28th Dec 20174:13 pmRNSDirector/PDMR Shareholding
12th Dec 20173:18 pmRNSHolding(s) in Company
8th Dec 20173:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20174:00 pmRNSDirector/PDMR Shareholding
20th Nov 20177:00 amRNSFinal Results
25th Oct 201710:00 amRNSHolding(s) in Company
25th Oct 20179:50 amRNSHolding(s) in Company
29th Sep 20174:00 pmRNSDirector Declaration
27th Sep 20177:00 amRNSDirectorate Change
26th Sep 201712:41 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSResult of Statutory Audit Tender
30th Aug 20177:00 amRNSTrading Update
17th Aug 20173:29 pmRNSHolding(s) in Company
16th Jun 20179:00 amRNSHolding(s) in Company
14th Jun 20174:05 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSHalf-year Report
20th Apr 20177:00 amRNSAcquisition
18th Apr 20179:44 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSTrading Update
23rd Mar 20173:05 pmRNSDirector/PDMR Shareholding
13th Mar 20172:08 pmRNSHolding(s) in Company
16th Feb 20175:10 pmRNSHolding(s) in Company
14th Feb 201711:57 amRNSHolding(s) in Company
1st Feb 20177:00 amRNSCapital Markets Day
18th Jan 20174:34 pmRNSResult of AGM
18th Jan 20177:00 amRNSTrading Statement
9th Jan 201711:30 amRNSHolding(s) in Company
5th Jan 201711:26 amRNSHolding(s) in Company
22nd Dec 20164:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20163:35 pmRNSDirector Declaration
8th Dec 20163:00 pmRNSAnnual Financial Report & Notice of AGM
30th Nov 20164:00 pmRNSDirector/PDMR Shareholding
21st Nov 20167:00 amRNSFinal Results
19th Oct 20162:57 pmRNSHolding(s) in Company
31st Aug 20167:00 amRNSTrading Statement
15th Aug 20164:00 pmRNSHolding(s) in Company
13th Jun 20164:00 pmRNSNotice of Adoption of FRS 101
16th May 20167:00 amRNSHalf Year Announcement
8th Apr 201611:01 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSTrading Update
9th Mar 20167:00 amRNSAcquisition
17th Feb 201610:08 amRNSHolding(s) in Company
21st Jan 20161:46 pmRNSDirector/PDMR Shareholding
21st Jan 20167:00 amRNSDirectorate Change
20th Jan 20164:58 pmRNSResult of AGM
20th Jan 20167:00 amRNSFirst Quarter Trading Update
17th Dec 201510:00 amRNSDirector/PDMR Shareholding
11th Dec 201511:38 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.